Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients;Asociación entre el polimorfismo 4G/5G en el gen del inhibidor del activador del plasminógeno-1 (PAI-1) y el infarto agudo de miocardio con elevación del ST en pacientes jóvenes

Revista Espanola de Cardiologia

Volumn 62, Issue 4, 2009, Pages 365-372

  Isordia Salas, Irma ^a,b,e   Leaños Miranda, Alfredo ^a   Sainz, Irma M ^c   Reyes Maldonado, Elba ^b   Borrayo Sánchez, Gabriela ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL DE CARDIOLOGÍA   (Mexico)

^e NONE   (Mexico)

Author keywords

Coagulationfs; Fibrinolysis; Myocardial infarction; Plasminogen activator inhibitor 1; Thrombosis

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; HYPERTENSION; INFORMED CONSENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; ST SEGMENT ELEVATION;

ACUTE DISEASE; ADULT; ELECTROCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEXICO; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 66549111756     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70893-0     Document Type: Article

References (41)

1. Instituto Nacional de Estadística, Geografía e Informática. Disponible en: www.inegi.org.mx
2. W.E. Kraus Genetic approaches for the investigation of genes associated with coronary heart disease Am Heart J 140 2000 S27 S35
3. P.M. Mannucci, L. Bernardinelli, L. Foco, M. Galli, F. Ribichini, and M. Tubaro Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women J Thromb Haemost 3 2005 280 286 (Pubitemid 41623615)
4. H.P. Kholer, and P.J. Grant Plasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 342 2000 1792 1801 (Pubitemid 30390240)
5. T.K. Nordt, J. Lohrmann, and C. Bode Regulation of PAI-1 expression by genetic polymorphism. Impact on atherogenesis Thromb Res 103 Suppl 1 2001 S1 S5
6. P. Eriksson, B. Kallin, F.M. Van't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci U S A 92 1995 1851 1855
7. S. Dawson, A. Hamsten, B. Wiman, A. Henney, and S. Humphries Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity Arterioscler Thromb 11 1991 183 190
8. S.M. Boeckoldt, N.R. Bijsterveld, A.H. Moon, M. Levi, H.R. Buller, and R.J. Peters Genetic variation in coagulation and fibrinolytic protein and their relation with acute myocardial infarction: a systematic review Circulation 104 2001 3064 3068
9. L. Iacoviello, F. Burzotta, A. Di Castelnuovo, F. Zito, R. Marchioli, and M.B. Donati The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis Thromb Haemost 80 1998 1029 1030 (Pubitemid 28556713)
10. I. Juhan-Vague, S.D. Pyke, M.C. Alessi, J. Jespersen, F. Haverkate, and S.G. Thompson Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities Circulation 94 1996 2057 2063
11. M. Margaglione, G. Cappucci, D. Colaizzo, N. Giuliani, G. Vecchione, and E. Grandone The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease Arterioscler Thromb Vasc Biol 18 1998 152 156 (Pubitemid 28277590)
12. J.P. Collet, G. Montalescot, E. Vicaut, A. Ankri, F. Walylo, and C. Lesty Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality Circulation 108 2003 391 394 (Pubitemid 36935529)
13. L.A. Hindorff, S.M. Schwartz, D.S. Siscovick, B.M. Psaty, W.T. Longstreth Jr, and A.P. Reiner The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women J Cardiovask Risk 9 2002 131 137 (Pubitemid 34553593)
14. S. Ye, F.R. Green, P.Y. Scarabin, V. Nicaud, L. Bara, and S.J. Dawson The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde Thromb Haemost 74 1995 837 841
15. J. Ding, B.J. Nicklas, M.D. Fallin, N. De Rekeneire, S.B. Kritchevsky, and M. Pahor Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke Am Heart J 152 2006 1109 1115 (Pubitemid 44872986)
16. P.M. Ridker, C.H. Hennekens, K. Lindpaintner, M.J. Stampfer, and J.P. Miletich Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men Circulation 95 1997 59 62 (Pubitemid 27029943)
17. A. Hamsten, B. Wiman, U. De Faire, and M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl Med 313 1985 1557 1563 (Pubitemid 16177394)
18. J.B. Nilsson, K. Boman, J.H. Jansson, T. Nilsson, and U. Näslund The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase J Thromb Thrombolysis 26 2008 188 195
19. A.Y. Wang, P. Poon, F.M. Lai, L. Yu, P.C. Choi, and S.F. Lui Plasminogen activator inhibitor-gene polymorphism 4G/4G genotype and lupus nephritis and lupus in Chinese patients Kidney Int 59 2001 1520 1528 (Pubitemid 32281243)
20. M.W. Mansfield, M.H. Stickland, and P.J. Grant PAI-concentrations in first-degree relatives of patients with non-insulin dependant diabetes: metabolic and genetic associations Thromb Haemost 77 1997 357 361 (Pubitemid 27084930)
21. D. Tassies, G. Espinosa, F.J. Muñoz-Rodriguez, C. Freire, R. Cervera, and J. Monteagudo The 4G/5G polymorphism of the type 1 plasminogen activators inhibitor gene and thrombosis in patients with antiphospholipid syndrome Arthritis Rheum 43 2000 2349 2358
22. R.J. Pegoraro, and N. Ranjith Plasminogen activator inhibitor type 1 (PAI-1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in young Asian Indians with acute myocardial infarction Cardiovasc J South Afr 16 2005 266 270 (Pubitemid 41789595)
23. S. Ruiz-Quezada, M. Vázquez-Del Mercado, I. Parra-Rojas, H. Rangel Villalobos, C. Best-Aguilera, and L.V. Sanchez-Orozco Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters Ann Genet 47 2004 155 162 (Pubitemid 38748498)
24. W.C. Hooper, C. Lally, H. Austin, M. Renshaw, A. Dilley, and N.K. Wenger The role of the t-PAI/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism Thromb Res 99 2000 223 230 (Pubitemid 30608700)
25. G.B. Boncoraglio, A. Bodini, C. Brambila, M.R. Carriero, E. Ciusani, and E.A. Parati An Effect of the PAI-1 4G/4G polymorphism on cholesterol levels may explain conflicting association with myocardial infarction and stoke Cerebrovasc Dis 22 2006 191 195 (Pubitemid 44114463)
26. I. Juhan-Vague, P.E. Morange, C. Frere, M.F. Aillaud, M.C. Alessi, E. Hawe HIFMECH Study Group The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study J Thromb Haemost 1 2003 2322 2329
27. A.R.P. Walker, and P. Sareli Coronary hearth disease: outlook for Africa JR Soc Med 90 1997 23 27 (Pubitemid 27062866)
28. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction J Am Coll Cardiol 36 2000 959 969
29. J.L. Ferguson, G.J. Beckett, M. Stoddart, S.W. Walker, and K.A. Fox Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction Heart 88 2002 343 347
30. M. Margaglione, E. Grandone, G. Cappuci, D. Colaizzo, N. Giuliani, and G. Vecchione An alternative method for PAI-1 promoter polymorphism (4G/5G) typing Thromb Haemost 77 1997 605 606
31. T. Sugano, H. Tsuji, H. Masuda, K. Nakagawa, H. Mishimura, and T. Kasahara Plasminogen activator inhibitor-1 promoter 4G75G genotype is not a risk factor for myocardial infarction in a Japanese population Blood Coagul Fibrinolysis 9 1998 201 204 (Pubitemid 28216267)
32. M.F. Sampaio, M.H. Hirata, R.D. Hirata, F.C. Santos, R. Piciotti, and A.D. Luchessi AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults Clin Chim Acta 377 2007 154 162 (Pubitemid 44914068)
33. R. Junker, J. Heinrich, H. Schutle, M. Tataru, E. Khöler, and R. Schönfeld Plasminogen activator inhibitor-1 4G/5G polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men Blood Coagul Fibrinolysis 9 1998 597 602 (Pubitemid 28520156)
34. M. Eliasson, K. Asplund, P.E. Ervin, and D. Lundblad Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin: The Northern Sweden MONICA Study Atherosclerosis 113 1995 41 53
35. M. Henry, D.A. Tregouet, M.C. Alessi, M.F. Aillaud, S. Visvikis, and G. Siest Metabolic determinants are much moreimportant than genetic polymorphism in determining the PAI-1 and antigen plasma concentrations: a family study with part of the Stanislas Cohort Arterioscler Thromb Vasc Biol 18 1998 84 91 (Pubitemid 28047603)
36. F. Burzotta, A. Di Castelnuovo, C. Amore, A. D'Orazio, M.B. Donati, and L. Iacoviello The role of 4G/5G polymorphism in the regulation of plasma levels of PAI-1; a model of interaction between genetic and environmental factors Cardiologia 43 1998 83 88
37. N.H. Naran, N. Chetty, and N.J. Crowther The influence of metabolic syndrome components on plasma PAI-1 concentration is modified by the PAI-1 4G/5G genotype and ethnicity Atherosclerosis 196 2008 155 163
38. M. Serrano Ríos The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population Diab Obes Metab 9 2007 134 136
39. A. Panahloo, V. Mohamed-Ali, R.P. Gray, S.E. Humphries, and J.S. Yudkin Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene. Atherosclerosis 168 2003 297 304 (Pubitemid 36703329)
40. B.E. Sobel, D.J. Taatjes, and D.J. Schneider Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 1979 1989 (Pubitemid 37433189)
41. J. Shindo, T. Ishibashi, M. Kijima, K. Nakazato, K. Nagata, and K. Yokoyama Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes Coron Artery Dis 2 2001 573 579 (Pubitemid 33097416)